The study by Pejhan et al. provides an important contribution to the ongoing debate regarding the significance of isolated angiitis of the vasa vasorum (AVV) and peri-adventitial small vessel vasculitis (SVV) in temporal artery biopsies. ^{Reference Pejhan, Barra and Basharat1} Through the re-examination of 72 biopsies paired with clinical follow-up, the authors demonstrate that isolated AVV/SVV is not a benign or incidental finding but instead identifies a subgroup of patients at higher risk of either harboring giant cell arteritis (GCA) or developing it over time.

Several strengths of this work deserve emphasis. The blinded re-assessment of all biopsies with standardized criteria, combined with integration of one–year clinical outcomes, provides a robust methodological framework. The finding that all biopsy-proven temporal arteritis cases were accompanied by small-vessel inflammation reinforces the biological link between AVV/SVV and GCA. Equally notable is the observation that 26% of patients with isolated AVV/SVV subsequently acquired a clinical diagnosis of GCA, a rate twice as high as in patients with non-inflamed biopsies. These data support the concept that AVV/SVV may represent an early, focal or partially treated stage of GCA, particularly in patients with high pre-test clinical probability.

The study also highlights important practical issues. Sampling variability and treatment-related modifications remain major challenges in temporal artery biopsy interpretation. The authors’ photomicrographic demonstration of spatial heterogeneity, with TA and AVV/SVV co-existing in different biopsy segments, underscores the risk of misclassification when sections are limited or non-serial. ^{Reference Cavazza, Muratore and Boiardi2} This strongly argues for a standardized, semi-serial histopathologic approach and for uniform reporting of small-vessel changes.

Nevertheless, some limitations warrant consideration. The single-center design and relatively modest cohort size may limit generalizability, and the semi-quantitative characterization of inflammatory cell subsets does not allow for deeper immunophenotypic insights. Broader validation in multi-institutional cohorts, ideally with integration of molecular or immunoprofiling approaches, will be valuable. Moreover, the absence of universally accepted diagnostic criteria for AVV/SVV remains a major barrier to consistent interpretation across pathology practices. ^{Reference Restuccia, Cavazza and Boiardi3–Reference Belilos, Maddox and Kowalewski5}

Overall, this article makes a compelling case for the clinical relevance of isolated AVV/SVV and calls for a shift in how these findings are interpreted. Rather than being dismissed as “nonspecific,” they should be recognized as potentially actionable histopathologic markers, prompting closer clinical surveillance and follow-up. The study represents a significant step toward resolving a long-standing diagnostic gray zone in temporal artery pathology and has meaningful implications for both pathologists and clinicians involved in the care of patients at risk for vision- and life-threatening complications of GCA.